Iodixanol is a contrast agent for injection, suitable for intraconical angiography, cardiovascular and cerebral angiography, and intravenous urography. Its principle of action is to combine with iodine to absorb X-rays in blood vessels or tissues to cause image display.
This report contains market size and forecasts of Iodixanol API in global, including the following market information:
Global Iodixanol API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Iodixanol API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Iodixanol API companies in 2021 (%)
The global Iodixanol API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Original Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Iodixanol API include GE Healthcare, Hengrui Medicine, Daiichi Sankyo, YRPG and BeiLu Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Iodixanol API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Iodixanol API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iodixanol API Market Segment Percentages, by Type, 2021 (%)
Original Drug
Generic Drug
Global Iodixanol API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iodixanol API Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Iodixanol API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Iodixanol API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Iodixanol API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Iodixanol API revenues share in global market, 2021 (%)
Key companies Iodixanol API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Iodixanol API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Hengrui Medicine
Daiichi Sankyo
YRPG
BeiLu Pharma